Absent or low expression of T-cell receptor zeta-chain in T cells infiltrating human pathological skin conditions
- PMID: 12420108
- DOI: 10.1007/s00403-002-0343-x
Absent or low expression of T-cell receptor zeta-chain in T cells infiltrating human pathological skin conditions
Abstract
The T-cell receptor (TCR) zeta-chain is involved in signal transduction necessary for T-cell activation and subsequent proliferation. Expression of the TCR zeta-chain in vivo has been studied by a variety of technical approaches on different cell and tissue specimen. However, the in situ situation concerning the expression of the TCR zeta-chain has not yet been investigated on infiltrating T lymphocytes in neoplastic and inflammatory cutaneous diseases. In this study, we analysed the expression of the TCR zeta-chain in a number of skin tissues affected by established inflammatory and neoplastic conditions. Serial sections of different tissue specimens were stained immunoenzymatically for CD3 and TCR zeta-chain expression. No or at most scarce expression of TCR zeta-chain was detectable in the inflammatory and neoplastic skin conditions investigated as compared to CD3-positive cells. It is possible that this TCR zeta-chain deletion is induced by the skin microenvironment as an effect of local immunoregulatory influences. Alternatively, lymphocytes located in the skin may generally not express this molecule. In our study, tumour-infiltrating T lymphocytes of CTCL were negative for TCR zeta-chain expression. It has been hypothesized that downregulation of the TCR zeta-chain on tumour-infiltrating T lymphocytes is a mechanism by which neoplastic cells escape the cellular immune response. Our findings showing the absence or reduction of TCR zeta-chain expression also in inflammatory skin lymphocytic infiltrates is not consistent with a pivotal role of the TCR zeta-chain in the process of immune escape of tumour cells.
Similar articles
-
Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.Arthritis Rheum. 2003 Jul;48(7):1948-55. doi: 10.1002/art.11072. Arthritis Rheum. 2003. PMID: 12847689
-
Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients.Am J Nephrol. 2008;28(1):152-7. doi: 10.1159/000110020. Epub 2007 Oct 19. Am J Nephrol. 2008. PMID: 17951997
-
Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus.Arthritis Rheum. 2002 Jan;46(1):163-74. doi: 10.1002/1529-0131(200201)46:1<163::AID-ART10065>3.0.CO;2-J. Arthritis Rheum. 2002. PMID: 11817588
-
Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus.Int Rev Immunol. 2004 May-Aug;23(3-4):273-91. doi: 10.1080/08830180490452594. Int Rev Immunol. 2004. PMID: 15204089 Review.
-
Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.Int Rev Immunol. 2004 May-Aug;23(3-4):245-63. doi: 10.1080/08830180490452602. Int Rev Immunol. 2004. PMID: 15204087 Review.
Cited by
-
YKL-40 inhibits melanoma progression and metastasis by inducing immune cell infiltration in a mouse model.Sci Rep. 2025 Mar 3;15(1):7426. doi: 10.1038/s41598-025-92522-7. Sci Rep. 2025. PMID: 40033096 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical